Made in Brunel Software Innovation 2013
The School held its third ‘Made in Brunel – Software Innovation’ event on 7 March. The event provided an opportunity for selected Level 2 and Level 3 (final year) undergraduate students to display and demonstrate their ideas and project work. A large turnout gave the event a real buzz, as companies, academics, undergraduate and postgraduate students viewed a selection of novel software applications. The event included:
- Level 2 group project prototypes for android-based mobile applications.
- A range of innovative final year projects – including haptic advertising systems, gaming environments and medical image analysis.
The event was well-supported by industry and prizes were awarded by Cisco, GlaxoSmithKline, Merck, Sky, Sporting Solutions, Steria and Xerox – winning students received iPads, Kindle Fires and vouchers. The industry representatives were extremely impressed by both the students and their work.
Events like this provide evidence of our key relationships with industry which, very importantly, exposes the quality of our students and pushes them to improve the innovative nature and quality of their work.
The event enabled me to pitch the application to external stakeholders and industry experts. I found the feedback extremely helpful in highlighting areas of improvement within my project and the feedback overall was encouraging and positive. Samir Harrar (Level 3) Winner of GlaxoSmithKline Innovative FYP Architecture prize
The event was highly successful and a truly unique experience, one which I was thrilled to take part in Lawrence Monk (Level 2) Winner of Sky Innovative Smartphone Application prize
The event was a very useful way of networking with potential employers, especially in gaining contacts within the organisations that could help with possible applications. I would encourage anyone who is thinking of participating in Made in Brunel to get involved as it is a great event that will help you in the transition from education to industry James Britton (Level 3) Group Project - Winner of Merck Healthcare Innovation prize